



	Questions : Lok Sabha




























Screen Reader Access
Skip to Main Content
Skip to Navigation



Text Size

                                A

                                A
A















हिन्दी मे








Parliament of India Lok Sabha House of the
                        People






* Special Characters not allowed












India Time 


Your Time 


                        Monday,
                        11 April 2022









HomeMembersSitting MembersMembers Home PageMembers' PortalContact DetailsMembers SearchStatistical AnalysisAttendance of MembersHandbook Members Since 1952Digitized Who's WhoOthers BusinessProvisional CalendarList of BusinessPapers to be LaidList of Private Members' BusinessBulletin-IDigitized Lok Sabha Bulletin Part IBulletin-IIStatement of WorkSpecial Mentions (ZERO HOUR)Resume of WorkDigitized Resume of Work done by Lok Sabha QuestionsHomeQuestion ListStatus of notices of questionQuestions CalendarGrouping of Ministries - AlphabeticalOfficers in Min./Dept. Dealing with Parliamentary WorkQuestion SearchSupplementary Questions DebatesIntroductionSynopsisUncorrected DebateText of DebateDigitized DebatesConstituent Assembly DebatesWit And HumourDebate SearchHindi FontsDisclaimer Papers LaidPapers Laid on the Table of the House LegislationIntroduction(How Bill Becomes Act)Bills IntroducedBills PassedBills PendingBills AssentedBills LapsedBills WithdrawnBills NegativedBills Search Disclaimer CommitteesIntroductionChairpersonSummary of WorkCommittee Meetings ScheduleBills Referred to CommitteesReports PresentedDigitized ReportsPress ReleaseMembership SearchToday's Committee MeetingsCommittee Subject SelectedDepartment Related-RS Govt. AssurancesSANSAD TVIntranet





HomeQuestion ListStatus of notices of questionQuestions CalendarGrouping of Ministries - AlphabeticalOfficers in Min./Dept. Dealing with Parliamentary WorkQuestion SearchSupplementary Questions











Download as PDF




Print












PDF/WORD(Hindi)


PDF/WORD




                                    GOVERNMENT OF INDIA
                                





                                    MINISTRY OF
                                    CHEMICALS AND FERTILIZERS






                                    LOK SABHA
                                





UNSTARRED 


                                    QUESTION NO:
                                

3698






                                    ANSWERED ON: 
                                

17.03.2020






Drug Import and Export




Ramcharan Bohra














                        Will the Minister of





CHEMICALS AND FERTILIZERS


                        be pleased to state:-















Will the Minister of CHEMICALS AND FERTILIZERS be pleased to state:(a) the details regarding the quantity and cost of import and export of medicines/drugs during each of the last three years and the current year, country-wise; (b) whether the country is dependent on imports particularly from China to meet the heavy demand of essential medicines and Active Pharmaceutical Ingredients; (c) if so, the details thereof and the reasons therefor; and (d) the measures taken by the Government to encourage Indian Pharmaceutical companies to increase their production so as to reduce the dependency on imports and also to promote export of medicines/ drugs?






ANSWER




(a):	The details of quantity and cost of import and export of medicines/drugs during each of the last three years and the current year, major country-wise is as following :DRUG FORMULATIONS, BIOLOGICALS Import data from 2016-2019:Country	2016-17Volume (in Kgs)	2016-17(Value in US $)	2017-18Volume (in Kgs)	2017-18(Value in US $)	2018-19Volume (in Kgs)	2018-19 (Value in US $)	2019-20Volume (in Kgs)(April 19-Dec 19)	2019-20 (Value in US $)(April 19-Dec 19)USA	457463	285890072 	595831	309482618 	683589	270175979 	722982	232435316Germany	553743	232268654 	842317	207469300 	937470	200861663 	750863	149684304France	224924	141889389 	227511	122286786		401566	131668335 	525783	110950747China	800533	135207004 	1292226	128771468 	1704937	149498662 	1495056	147294699Switzerland	111900	105552151 	194362	132665826 	521474	302047568 	509253	219759657Total Imports from all countries	4325475	1662175762	9140935	1840778441	19030788	2018563123	17914366	1767129089 DRUG FORMULATIONS, BIOLOGICALS Export data from 2016-2019:Country	2016-17Volume (in Kgs)	2016-17(Value in US $)	2017-18Volume (in Kgs)	2017-18(Value in US $)	2018-19Volume (in Kgs)	2018-19 (Value in US $)	2019-20Volume (in Kgs)(April 19-Dec 19)	2019-20 (Value in US $)(April 19-Dec 19)USA	72169919	5057829263 	67492681	4601523089 	55630576	5327205621 	40309985	43736750242UK	18810063	439431269 	13772256	454450341 	11325510	524317178 	6608351	329074941South Africa	8613140	389027509 	8738119	479530849 	8441085	525454816 	5170803	392701354China	354846	23178436 	520470	26769082 	667317	33152930 	342458	31007724Total Exports to all countries	352124554	12666440148	320564438	12909093200	307467690	14388794412	188713934	12017224892(Source: DGCIS Kolkata)(b) & (c):As per Directorate General of Commercial Intelligence and Statistics (DGCIS) Kolkata, during the year 2018-19, the share of China in the total bulk drugs/APIs imported into the country was approximately 67 per cent. Some of these bulk drugs/APIs are also used for manufacturing essential medicines. The imports from China are mainly due to economic considerations. The details of India’s imports of Bulk Drugs/ Drug Intermediates and Drug Formulations (including from China) are as under:Import of Pharmaceutical productsItem	Imports during 2018-19 (In US $ mn)	Imports from China during 2018-19(US $ mn)	Percent of Imports from ChinaBulk Drug, Drug Intermediate	3560.3	2405.42	67.56%Drug Formulations, Biologicals	2018.56	149.49 	7.40% (d): The policies formulated by Government from time to time are designed to minimize country’s dependence on imports and to give fillip to indigenous manufacturing. In this direction, with the objective to ensure drug security in the country by increasing the efficiency and competitiveness of domestic pharmaceutical industry the Department of Pharmaceuticals has prepared an umbrella scheme for Development of Pharmaceuticals Industry with the following sub-schemes: (a) Assistance to Bulk Drug Industry for Common Facility Centre; (b) Assistance to Medical Device Industry for Common Facility Centre; (c) Pharmaceuticals Technology Upgradation Assistance Scheme (PTUAS); (d) Assistance to Pharmaceutical Industry for Common Facilities; and (e) Pharmaceutical Promotion Development Scheme (PPDS). xxxxx
























HomeArchiveIndex to Select Questions (1984-1999)Ballot ListStatistical Statements Relating to QuestionsUploading of Questions - Status QueryProcedure for Sending Text of Questions & AnswersDemarcation of responsibilities in Govt. of IndiaBrochure on Statutory Corporations, Companies and Other Bodies in Which the Government of India have financial or controlling interestHighlights pertaining to questions of 17th Lok Sabha






Contact Us 
Disclaimer











        Developed and Hosted by National Informatics Centre (NIC)

Content on this website is published,
            managed & maintained by Software Unit, Computer (HW & SW) Management. Branch,
            Lok Sabha Secretariat





HomeMembersBusinessQuestionsDebatesPapers Laid


LegislationCommitteesSANSAD TVIntranetSecretariatPRIDE


RecruitmentSC/ST ReservationConferenceParliament Library


About ParliamentPhoto GalleryRelated LinksRTITendersFAQ


SpeakerDy. SpeakerLeader of the HousePanel of ChairpersonsContact UsFeedback


Council of MinistersPublications of MinistriesParliamentry ProceduresJournal of Parliamentary Information
Visitor's Counter:113185344







Copyright
Privacy Policy
Disclaimer
Terms &
                Conditions

                Accessibility Statement
Accessibility
                Options
Feedback
Site Map







